Champions Oncology (CSBR) EBT Margin (2010 - 2026)
Champions Oncology (CSBR) posted EBT Margin of 3.58% for Q2 2026, down 149.98% on a QoQ basis from 1.43% in Q1 2026, and up 1232.0% year-over-year from 0.27% in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) EBT Margin (2010 - 2026) Analysis & Trends
Champions Oncology has reported EBT Margin for 17 years, with the latest figure at 3.58% in Q2 2026.
- On a quarterly basis, EBT Margin rose 1232.0% year-over-year to 3.58% in Q2 2026; TTM through Apr 2026 was 1.56%, a 969.0% decrease from a year earlier, with the FY2026 full-year figure at 1.56%, down 969.0% from the prior year.
- EBT Margin was 3.58% for Q2 2026 at Champions Oncology, down from 1.43% in the prior quarter.
- The five-year high for EBT Margin was 26.52% in Q1 2025, with the low at 20.96% in Q1 2024.
- Average EBT Margin over 5 years is 4.36%, with a median of 2.44% recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: EBT Margin surged 4747 bps in 2025, then tumbled 2795 bps in 2026.
- Over 5 years, EBT Margin stood at 0.01% in 2022, then sank by 127001 bps to 17.8% in 2023, then soared by 131 bps to 5.48% in 2024, then slumped by 69 bps to 1.7% in 2025, then sank by 311 bps to 3.58% in 2026.
- The last three EBT Margin figures came in at 3.58% (Q2 2026), 1.43% (Q1 2026), and 1.7% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 6.89% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 21.44% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 5.30% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 4.47% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -0.18% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -283.75% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -3.58% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -105.20% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -15,194.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3.58% |
| Jan 31, 2026 | -1.43% |
| Oct 31, 2025 | 1.70% |
| Jul 31, 2025 | -3.23% |
| Apr 30, 2025 | -15.90% |
| Jan 31, 2025 | 26.52% |
| Oct 31, 2024 | 5.48% |
| Jul 31, 2024 | 9.49% |
| Apr 30, 2024 | -1.36% |
| Jan 31, 2024 | -20.96% |
| Oct 31, 2023 | -17.80% |
| Jul 31, 2023 | -20.21% |
| Apr 30, 2023 | -19.44% |
| Jan 31, 2023 | -18.96% |
| Oct 31, 2022 | -0.01% |
| Jul 31, 2022 | -2.20% |
| Apr 30, 2022 | -2.69% |
| Jan 31, 2022 | 6.05% |
| Oct 31, 2021 | 2.45% |
| Jul 31, 2021 | -1.40% |